Effect of biological agents on B-lymphocyte subpopulations in patients with systemic lupus erythematosus

Objective: to evaluate the effect of different biological agents (BAs), including rituximab (RTM) and belimumab (BLM) combination therapy, on B-lymphocyte subpopulations during a follow-up of patients with systemic lupus erythematosus (SLE).Patients and methods. The investigation enrolled 64 patient...

Full description

Bibliographic Details

Published in:	Современная ревматология
Main Authors:	A. A. Mesnyankina, S. K. Solovyev, E. A. Aseeva, A. P. Aleksankin, E. N. Aleksandrova, E. L. Nasonov
Format:	Article
Language:	Russian
Published:	IMA-PRESS LLC 2019-03-01
Subjects:	systemic lupus erythematosus b-lymphocyte subpopulations rituximab belimumab
Online Access:	https://mrj.ima-press.net/mrj/article/view/883